Immunotherapy-Second Opinion

Despite an initial prognosis of only six to eight months to live, Ronald Eckert, MD, is thriving after undergoing a new immunotherapy treatment for stage 4 melanoma. Four years after the treatment, he feels he is cured and shares his story. Medical experts discuss the groundbreaking immunotherapy re...

Full description

Other Authors: Infobase,, John McLean Media (Firm)
Format: Video
Language: English
Published: [Place of publication not identified] : John McLean Media, [2017]
Distributed by Infobase,
Physical Description: 1 online resource (1 video file (26 min., 46 sec)) : sound, color.
Series: Second Opinion.
Subjects:

CMU Electronic Access

Electronic Resource Click Here
LocationCall Number: Status
CMU Electronic Access Available